IRIS
CORELLI, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.827
EU - Europa 9.064
AS - Asia 1.457
OC - Oceania 23
SA - Sud America 22
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.794
GB - Regno Unito 2.772
IE - Irlanda 1.632
CN - Cina 1.213
UA - Ucraina 1.035
IT - Italia 960
SE - Svezia 825
FR - Francia 688
DE - Germania 592
FI - Finlandia 281
RU - Federazione Russa 107
SG - Singapore 80
TR - Turchia 74
ES - Italia 33
CA - Canada 27
CZ - Repubblica Ceca 25
BE - Belgio 24
AU - Australia 22
IN - India 20
VN - Vietnam 16
CL - Cile 14
JP - Giappone 14
PL - Polonia 13
RO - Romania 13
NL - Olanda 12
AT - Austria 8
HK - Hong Kong 7
EG - Egitto 6
KR - Corea 6
SI - Slovenia 6
BR - Brasile 5
EE - Estonia 5
PK - Pakistan 5
ZA - Sudafrica 5
CH - Svizzera 4
EU - Europa 4
HU - Ungheria 4
IR - Iran 4
SA - Arabia Saudita 4
BG - Bulgaria 3
GR - Grecia 3
IM - Isola di Man 3
LK - Sri Lanka 3
MX - Messico 3
AL - Albania 2
DK - Danimarca 2
IL - Israele 2
KZ - Kazakistan 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
SY - Repubblica araba siriana 1
Totale 21.412
Salva come PNG Salva come JPEG
Città #
Southend 2.595
Dublin 1.629
Fairfield 1.519
Menlo Park 1.469
Jacksonville 851
Chandler 818
Woodbridge 725
Ashburn 656
Wilmington 647
Houston 552
Cambridge 502
Seattle 502
Ann Arbor 347
Siena 311
Beijing 305
Princeton 297
Nanjing 290
Boardman 149
Nanchang 125
Helsinki 107
San Diego 96
San Mateo 92
Fremont 84
Moscow 73
Shenyang 65
New York 64
Izmir 61
Tianjin 54
Florence 53
Hebei 53
Singapore 48
Düsseldorf 44
Shanghai 42
Dearborn 41
Norwalk 40
Venezia 40
Milan 39
London 38
Rome 38
Changsha 36
Jiaxing 31
Kunming 30
Lancaster 29
Redwood City 24
Brussels 22
Hangzhou 22
Málaga 22
Anguillara Sabazia 20
Guangzhou 20
San Francisco 20
Jinan 19
Ningbo 18
Zhengzhou 17
Brno 14
Changchun 12
Chicago 12
Dong Ket 12
Melbourne 11
Naples 11
Washington 11
Mestre 10
Philadelphia 10
Rende 10
Taizhou 10
Mogliano 9
Munich 9
Urlati 9
Bonndorf 8
Candiolo 8
Cardiff 8
Kilburn 8
Lanzhou 8
Saint Petersburg 8
Toronto 8
Vienna 8
Aligarh 7
Montréal 7
Tappahannock 7
Bari 6
Galatone 6
Haikou 6
Hefei 6
Indiana 6
Latina 6
Los Angeles 6
Sydney 6
Tokyo 6
Certaldo 5
Edinburgh 5
Frankfurt am Main 5
Livorno 5
Madrid 5
Mestrino 5
Montreal 5
Paris 5
Shenzhen 5
Tallinn 5
Valencia 5
Amsterdam 4
Arconate 4
Totale 16.143
Salva come PNG Salva come JPEG
Nome #
Ligandi TRPV1 314
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 275
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 217
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 7. Synthesis and Pharmacological Evaluation of 4-Quinolone-3-carboxamides and 4-Hydroxy-2-quinolone-3-carboxamides as High Affinity Cannabinoid Receptor 2 (CB2R) Ligands with Improved Aqueous Solubility 198
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach 197
Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: Involvement of the GABAB and cannabinoid CB1 receptors 188
null 186
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 186
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury 177
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA B receptor 170
Synthesis of an original oxygenated taxuspine X analogue: a versatile non-natural natural product with remarkable P-gp modulating activity 167
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains 165
Antifungal agents. 10. New derivatives of 1-[(Aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-Candida activity and Quantitative Structure-Analysis Relationship studies 163
Screen of unfocused libraries identified compounds with direct or synergistic antibacterial activity 161
Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy 160
Synthesis, 1 structural properties, and pharmacological evaluation of 2-(acylamino)thiophene-3-carboxamides and analogues thereof 159
Dihydro-alkylthio-benzyl-oxopyrimidines as Inhibitors of Reverse Transcriptase: Synthesis and Rationalization of the Biological Data on Both Wild-Type Enzyme and Relevant Clinical Mutants 158
Simplified Analogues of Immucillin-G Retain Potent Human Purine Nucleoside Phosphorylase Inhibitory Activity 155
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 152
Computational studies of competitive inhibitors of nitric oxide synthase (NOS) enzymes: towards the development of powerful and isoform-selective inhibitors 150
Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABAB receptor 149
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model 148
Anxiety-like behaviors at the end of the nocturnal period in sP rats with a “history” of unpredictable, limited access to alcohol. 147
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 1. Synthesis and Structure-Activity Relationship of a Class of Human Immunodeficiency Virus type 1 Integrase Inhibitors 145
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 144
Synthesis and Interaction with Copper(II) Cations of Cyano- and Aminoresorcin[4]arenes 144
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 144
Synthesis of reactive cytidine derivatives as building blocks for cross-linking oligonucleotides 143
NUOVA TERAPIA PER IL TRATTAMENTO DELL'IPERURICEMIA NELLA SINDROME DI LESCH-NYHAN 142
Parallel solution phase synthesis of 4-dialkylamino-2-methylsulfonyl-6-vinylpyrimidines 141
Microwave-enhanced Sonogashira coupling reaction of substituted pyrimidinones and pyrimidine nucleosides 141
Solid phase synthesis of 5,6-disubstituted pyrimidinone and pyrimidindione derivatives 141
Solid-phase synthesis (SPS) of substituted uracils via Oxone® cleavage methodology 141
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 141
Chiral Azole Derivatives, 3. Synthesis of the Enantiomers of the Potent Aromatase Inhibitor 1-[2-Benzofuranyl(4-chlorophenyl)methyl]-1H-imidazole 141
Synthetic bioactive olivetol-related amides: the influence of the phenolic group in cannabinoid receptor activity 141
Towards new methodologies for the synthesis of biologically interesting 6-substituted pyrimidines and 4(3H)-pyrimidinones 140
Inhibition of alcohol self-administration by positive allosteric modulators of the GABA(B) receptor in rats: lack of tolerance and potentiation of baclofen 140
Synthesis, molecular modeling studies, and pharmacological activity of selective A1 receptor antagonists 140
Combinatorial chemistry as a tool for targeting different stages of the replicative HIV-1 cycle 139
Pyrrolobenzodiazepines and related systems. 2. Synthesis and biological properties of isonoraptazepine derivatives 139
A combination of docking/dynamics simulations and pharmacophoric modeling to discover new dual c-Src/Abl kinase inhibitors 139
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 136
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 136
A Novel Route to Calix[4]arenes. 2. Solution- and Solid-State Structural Analyses and Molecular Modeling Studies 136
Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice 134
Design, Synthesis, and Pharmacological Characterization of Indole-3-ylacetamides, Indole-3-yloxoacetamides, and Indole-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 134
Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies 133
Polycondensed heterocycles. V. Synthesis of 5H,11H-Pyrrolo[2,1-c][1,4]benzothiazepine 131
Antifungal Agents. 11.N-Substituted Derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3yl)methyl]-1H-imidazole: Synthesis, Anti-Candida Activity, and QSAR Studies 130
Novel Substituted Aminoalkylguanidines as Potential Antihyperglycemic and Food Intake-Reducing Agents. 130
An improved synthesis of solid-supported reagents (SSRs) for selective acylation of amines by microwave irradiation 130
Probing the substrate specificity for lipases. II. Kinetic and Modeling Studies on the Molecular Recognition of 2-Arylpropionic Esters by Candida rugosa and Rhizomucor miehei Lipases 130
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice 130
Probing the substrate specificity for lipases. A CoMFA approach for predicting the hydrolysis rates of 2-arylpropionic esters catalyzed by Candida rugosa lipase 129
Solid Phase Synthesis of 2,6-Disubstituted-4(3H)-pyrimidinones Targeting HIV-1 Reverse Transcriptase 128
New solid-supported reagents (SSRs) for selective acylation of amines 128
A genetic-function-approximation-based QSAR model for the affinity of arylpiperazines toward a1 adrenoceptors 128
Solution-phase parallel synthesis of S-DABO analogues 127
Reducing effect of saikosaponin A, an active ingredient of Bupleurum falcatum, on alcohol self-administration in rats: Possible involvement of the GABAB receptor 127
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands 126
Reduction by the positive allosteric modulator of the GABAB receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the “sipper” procedure 126
6-Vinyl pyrimidine and pyrimidinone derivatives and the use thereof 125
Stereoselective synthesis of α-aryl-2-benzofuranmethanamines and α-aryl-1H-indole-2-methanamines through palladium-mediated annulation of chiral α-arylpropargylamines 125
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists 124
Fibroblast growth factors and their inhibitors 124
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 2. Synthesis and Structure-Activity Relationship of Potent and Selective Cannabinoid-2 Receptor Agonists Endowed with Analgesic Activity in Vivo 124
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile. 124
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor 123
Rational design and synthesis of homochiral azole antifungal agents 123
Exploring the Synthesis of Masked Phosphoramido 6-Vinylcytidine Derivatives as Building Blocks for Cross-Linking Oligonucleotides 122
Synthesis and biological evaluation of conformationally restricted analogs of tolmetin and ketorolac 122
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist 122
Three-Dimensional Quantitative Structure-Selectivity Relationships (3D-QSSR) Analysis Guided Rational Design of a Highly Selective Ligand for the Cannabinoid Receptor 2 121
Efficient synthesis of iminoctadine, a potent antifungal agent and polyamine oxidase inhibitor (PAO). 121
The tetramerization of 2,4-dimethoxycinnamates. A novel route to calixarenes 121
A new linker for anchoring/masking primary amines on solid support 121
The 4-Quinolone-3-carboxylic Acid Motif as a Multivalent Scaffold in Medicinal Chemistry 120
Cyclic Dipeptides - A Stereocontrolled Synthesis of (2s,3r,6r) and (2r,3r,6r)-6-tert-butoxycarbonylamino-3-methoxycarbonyl-2-methyl-5-oxope Rhydro-1,4-thiazepine 120
Total Synthesis of δ-Sanshool and Analogues Thereof 119
Studies towards the synthesis of the bicyclic 3,8-secotaxanediterpenoid system using a ring closing metathesis strategy 119
Practical synthesis of novel purine analogues as Hsp90 inhibitors. 118
A pharmacophore modeling approach to design new taxol® mimics: towards the synthesis of potential anticancer and MDR-reversing agent 118
The bioisosteric concept applied to cannabinoid ligands 118
Stereoselective synthesis of advanced intermediates en route to Taxuspine U and X: a study of macrocyclization via ring closing metathesis to highly constrained twelve-membered rings. 116
A combinatorial approach for the solid phase synthesis of 5,6-disubstituted pyrimidinones and pyrimidine derivatives 115
Studies toward Taxuspine X, a potent Multidrug - Resistance Reversing Agent, via ring closing metathesis strategy 115
Parallel Solution-Phase and Microwave-Assisted Synthesis of New S-DABO Derivatives Endowed with Subnanomolar Anti-HIV-1 Activity 113
Microwave-assisted ethylene-alkyne cross-metathesis: synthesis of chiral 2-(N-1-acetyl-1-arylmethyl)-1,3-butadienes 113
Molecular modeling as a powerful technique for understanding small-large molecules interactions 112
Synthesis, biological evaluation and pharmacophore generation of uracil, 4(3H)-pyrimidinone, and uridine derivatives as potent and selective inhibitors of parainfluenza 1 (Sendai) virus 112
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors 111
Enantioselective synthesis of 1-aryl-2-propenylamines: a new approach to a stereoselective synthesis of the Taxol® side chain. 111
Preparation of pyrimidine and pyrimidinone derivatives and their use for the treatment of HIV infections 111
Polycondensed heterocycles. VII. A convenient synthesis of pyrrolo[1,2-a]quinoxaline derivatives by intramolecular aromatic nucleophilic displacement 111
3D QSAR studies of the interaction between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones 110
Cyclic dipeptides. 4. On the Pummerer rearrangement of diastereomeric dehydrocyclolanthionine sulfoxides 110
Molecular modeling of azole antifungal agents active against Candida albicans .1. A comparative molecular field analysis study 110
Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase 110
Molecular Basis for the Binding of Competitive Inhibitors of Maize Polyamine Oxidase 109
Totale 13.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.222 588 151 256 691 284 302 304 520 334 367 139 286
2020/20213.319 176 327 45 346 136 403 191 489 410 318 298 180
2021/20222.279 174 338 147 219 59 71 135 82 85 263 208 498
2022/20233.402 226 225 471 491 330 717 71 278 350 67 107 69
2023/20242.418 127 41 168 143 89 591 854 73 13 42 38 239
2024/202547 47 0 0 0 0 0 0 0 0 0 0 0
Totale 21.600